Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ibrahim Alatwi"'
Autor:
Dikhnah Al Shehri, Omar I. Saadah, Mahmoud Mosli, Sherif Edris, Marfat Alatawy, Hanan Alatawi, Hadba Al-Amrah, Ibrahim Alatwi, Rashad Al-Hindi, Ahmad Bahieldin
Publikováno v:
Informatics in Medicine Unlocked, Vol 44, Iss , Pp 101415- (2024)
Background and aim: Inflammatory bowel disease (IBD) is a chronic and relapsing disorder that is strongly linked to intestinal microbiota alteration (dysbiosis). Anti-tumor necrosis factor-alpha (anti-TNF-α) therapies have revolutionized IBD treatme
Externí odkaz:
https://doaj.org/article/cb697f16e85344b8aa38ad8ab7a6b97d
Publikováno v:
Ectopic Pregnancy and Prenatal Diagnosis
Ectopic Pregnancy and Prenatal Diagnosis ISBN: 9781803558400
Ectopic Pregnancy and Prenatal Diagnosis ISBN: 9781803558400
Methotrexate is the standard medical management for ectopic pregnancy. Pharmacologically, it is a folic acid antagonist which inhibits DNA synthesis. 90% of appropriately selected un-ruptured none live ectopic pregnancy respond to methotrexate treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59feb6d108911dde1ddb9edd49799039
https://mts.intechopen.com/articles/show/title/medical-management-of-ectopic-pregnancy
https://mts.intechopen.com/articles/show/title/medical-management-of-ectopic-pregnancy
Preterm delivery is defined as delivery before 37 weeks completed gestation. It represents a major cause of neonatal morbidity and mortality and accounts for 5–10% of all deliveries. Cervical length assessment between 16–24 weeks and positive fet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d7eeae9897e23d80875512cd9db2d55
https://doi.org/10.5772/intechopen.96049
https://doi.org/10.5772/intechopen.96049
Autor:
Ibrahim Alatwi, Ahmed M. Hamdan, Khaled Al Karni, Abdurahman Alatawi, Fatimah Alshehri, Hanan AlKharboush
Publikováno v:
Cureus
Background and objective Anemia is a common prognosis of chronic kidney disease (CKD). It is predominantly managed with synthetic erythropoietin. The principal objective of this study was to compare the cost-effectiveness of the use of short-acting e